Close Menu

QuantumDx

John Burn has been appointed as a non-executive director of NHS England, QuantuMDx said this week.

NEW YORK (GenomeWeb) — QuantuMDx will use the proceeds from a recent financing round to optimize its handheld Q-POC molecular diagnostic device as well as several assays ahead of planned launches in 2015 and 2016.

NEW YORK (GenomeWeb News) – British molecular diagnostics company QuantuMDx has closed an $8.4 million investment round to further the development of a device for point-of-care testing, the firm said today.

NEW YORK (GenomeWeb News) – The Singapore Institute of Manufacturing Technology announced today a deal with QuantuMDx in support of the UK firm's development of a handheld point-of-care molecular diagnostic device.

NEW YORK (GenomeWeb News) – After years in development, a handheld point-of-care molecular diagnostic device from QuantuMDx is poised to hit the market next year with malaria and tuberculosis as its initial target markets, a company executive said last week on the sidelines of the 32nd Annual JP

QuantumDx CEO Elaine Warburton is being recognized for her work in the molecular diagnostics field and being dubbed an Officer of the Order of the British Empire.

QuantumDx CEO Elaine Warburton will become an Officer of the Order of the British Empire, the Newcastle, UK-based molecular diagnostics firm announced recently.

QuantumDx CEO Elaine Warburton will become an Officer of the Order of the British Empire, the Newcastle, UK-based molecular diagnostics firm announced recently.

NEW YORK (GenomeWeb News) – QuantuMDx said today that its subsidiary NorthGene has received accreditation from the UK's Ministry of Justice to perform legal DNA tests for parentage.

This story has been updated to clarify that QuantumDx has not yet invested in Pastel Bioscience.
UK-based biotech firm Pastel BioScience is building an array-based proteomics platform with the aim of accessing the entire human proteome.

Pages

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.